Institutional investors hold a majority ownership of LLY through the 67.84% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2017, these large investors purchased a net $2.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.9 Million shares of Eli Lilly and Co
BMO ASSET MANAGEMENT CORP. Bought 2.3 Million shares of Eli Lilly and Co
INVESTEC ASSET MANAGEMENT LTD. Bought 1.9 Million shares of Eli Lilly and Co